Devalued and distrusted : can the pharmaceutical industry restore its broken image? /

Devalued and distrusted : can the pharmaceutical industry restore its broken image? / / John L. LaMattina.

"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former P...

Full description

Saved in:
Bibliographic Details
:
ProQuest (Firm)
LaMattina, John L.
TeilnehmendeR:
ProQuest (Firm)
Year of Publication:2013
Language:English
Online Access:
Physical Description:ix, 125 p. :; col. ill.
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02530nam a2200373 a 4500
001 5001104475
003 MiAaPQ
005 20200520144314.0
006 m o d |
007 cr cn|||||||||
008 121010s2013 njuad sb 001 0 eng d
010 |z  2012032915 
020 |z 9781118487471 (pbk.) 
020 |a 9781118511299 (electronic bk.) 
035 |a (MiAaPQ)5001104475 
035 |a (Au-PeEL)EBL1104475 
035 |a (CaPaEBR)ebr10641813 
035 |a (CaONFJC)MIL422992 
035 |a (OCoLC)823389919 
040 |a MiAaPQ  |c MiAaPQ  |d MiAaPQ 
050 4 |a HD9665.5  |b .L36 2013 
082 0 4 |a 338.4/76151  |2 23 
100 1 |a LaMattina, John L. 
245 1 0 |a Devalued and distrusted  |h [electronic resource] :  |b can the pharmaceutical industry restore its broken image? /  |c John L. LaMattina. 
260 |a Hoboken, N.J. :  |b Wiley,  |c 2013. 
300 |a ix, 125 p. :  |b col. ill. 
504 |a Includes bibliographical references and index. 
505 8 |a Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts. 
520 |a "While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R&D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"--  |c Provided by publisher. 
533 |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. 
650 0 |a Pharmaceutical industry  |x Corrupt practices. 
655 4 |a Electronic books. 
710 2 |a ProQuest (Firm) 
856 4 0 |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1104475  |z Click to View 

Similar Items